Bullfrog AI
BFRGBFRG · Stock Price
Historical price data
Overview
Bullfrog AI Holdings, Inc. is a clinical-stage biotechnology company integrating explainable artificial intelligence with drug development to improve precision and success rates. Its core strategy is dual-faceted: developing an internal pipeline of in-licensed oncology and metabolic drug candidates and providing its proprietary AI/ML technology platforms as services to other life sciences organizations. The company's award-winning bfLEAP™ platform, licensed from Johns Hopkins APL, uses graph-based analytics to uncover hidden biological patterns from complex, multimodal data. Bullfrog aims to address the critical industry bottleneck of fragmented data and 'black box' AI models.
Technology Platform
A dual-platform AI stack: bfPREP™ for harmonizing fragmented biomedical data into AI-ready assets, and bfLEAP™, an award-winning, explainable graph-based AI platform licensed from Johns Hopkins APL, for uncovering biological patterns and drivers.
Opportunities
Risk Factors
Competitive Landscape
Bullfrog competes with pure-play AI biotechs (e.g., Exscientia, Recursion), large biopharma internal efforts, and data analytics vendors. Its differentiation hinges on its exclusive, explainable graph AI core (bfLEAP™) and its dedicated data harmonization platform (bfPREP™), but it must prove superior utility in a resource-intensive race.